14 Atrial Fibrillation Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Atrial Fibrillation Studies in San Francisco

NCT05836987Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation ...

San Francisco, CAPHASE35,350 participantsJohns Hopkins University

View Study Details

NCT05504356Recruiting

Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation

VIBRANT-AF seeks to: * Identify clinically relevant predictors of effectiveness and complications of AF ablation procedures in a prospective, US-based, multi-center, real-world longitudinal study * A...

San Francisco, CA1,125 participantsUniversity of California, San Francisco

View Study Details

NCT06995391Recruiting

Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity

Per the 2021 National Survey on Drug Use and Health administered by the U.S. Department of Health and Human Services, 85% of all American adults consume alcohol. Atrial fibrillation (AF) is the most c...

San Francisco, CANA1,000 participantsUniversity of California, San Francisco

View Study Details

NCT06455098Recruiting

A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

The purpose of this study is to demonstrate the safety and 12-month effectiveness of the BWI OMNYPULSE™ pulsed field ablation (PFA) platform for pulmonary vein isolation (PVI) in the treatment of part...

San Francisco, CANA440 participantsBiosense Webster, Inc.

View Study Details

NCT06701188Recruiting

Supportive Training After Cardiac Rehabilitation Including Virtual Engagement

The proposed research seeks to determine whether virtual coaching and social support focusing on key social cognitive factors will be an effective strategy for maintaining physical activity (PA) after...

San Francisco, CANA286 participantsUniversity of California, San Francisco

View Study Details

NCT05988411Recruiting

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

This is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control) clinical trial. The purpose of the study is to determine the role of adjunctive renal sympathetic denervation in...

San Francisco, CANA250 participantsVivek Reddy

View Study Details

NCT06585774Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

This study will be conducted to compare the efficacy of axatilimab versus placebo in combination with corticosteroids as initial treatment for moderate or severe chronic graft-versus-host disease (cGV...

San Francisco, CAPHASE3240 participantsIncyte Corporation

View Study Details

NCT07405359Recruiting

PVI Alone Versus PVI Plus PWI and SVCI With PFA

Catheter based ablation of atrial fibrillation (AF) is an established treatment modality for rhythm control of AF, with pulmonary vein isolation (PVI) being the cornerstone of this technique. While pu...

San Francisco, CANA220 participantsEdward Gerstenfeld, MD

View Study Details

NCT06853223Recruiting

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Lung transplant recipient survival lags other solid organ recipients, with the main early cause of death being primary graft dysfunction (PGD). PGD occurs in up to 1/3 of all recipients, is driven by ...

San Francisco, CAPHASE2120 participantsUniversity of California, San Francisco

View Study Details

NCT06754176Recruiting

Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation

The goal of this study is to assess the short-term effects of minimal and moderate drinking on atrial fibrillation (AFib) episodes in a real-world population diagnosed with 'come-and-go'/paroxysmal AF...

San Francisco, CANA100 participantsUniversity of California, San Francisco

View Study Details

NCT07110246Recruiting

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

This phase II trial studies how well de-escalating the drugs dabrafenib and trametinib works in treating patients with low-grade gliomas that have a BRAF V600 gene mutation. Dabrafenib and trametinib ...

San Francisco, CAPHASE296 participantsUniversity of California, San Francisco

View Study Details

NCT04337515Recruiting

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Patients in need of an allogeneic hematopoietic cell transplant (HCT) are at risk of developing graft-versus-host-disease (GVHD). In certain clinical situations, the optimal approach to minimize the r...

San Francisco, CANA90 participantsChristopher Dvorak

View Study Details

NCT05979389Recruiting

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Nonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and scarring is projected to be the leading cause of cirrhosis in the United States (U.S.) within the next few years. Women are a...

San Francisco, CAPHASE150 participantsUniversity of California, San Francisco

View Study Details

NCT06663722Recruiting

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

The purpose of this study is to see whether giving participants a combination treatment of Axatilimab and Extracorporeal Photopheresis (ECP) is effective against chronic Graft-versus-Host Disease (cGV...

San Francisco, CAPHASE249 participantsUniversity of Miami

View Study Details

About Atrial Fibrillation Clinical Trials in San Francisco

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 14 atrial fibrillation clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 9,416 participants. Research is being sponsored by Johns Hopkins University, University of California, San Francisco, Biosense Webster, Inc. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in San Francisco — FAQ

Are there atrial fibrillation clinical trials in San Francisco?

Yes, there are 14 atrial fibrillation clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 14 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated July 17, 2026 from ClinicalTrials.gov